UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 45

Sortiert nach

Expert Consensus on clinical application of FDG PET/CT in infection and inflammation

Annals of nuclear medicine, 2020-05, Vol.34 (5), p.369-376

2020

Volltextzugriff (PDF)

Characterization of the benign lesions with increased 68Ga-FAPI-04 uptake in PET/CT

Annals of nuclear medicine, 2021-12, Vol.35 (12), p.1312-1320

2021

Volltextzugriff (PDF)

[99mTc]3PRGD2 for integrin receptor imaging of esophageal cancer: a comparative study with [18F]FDG PET/CT

Annals of nuclear medicine, 2019-02, Vol.33 (2), p.135-143

2019

Volltextzugriff (PDF)

Evaluation of 99mTc-3PRGD2 integrin receptor imaging in hepatocellular carcinoma tumour-bearing mice: comparison with 18F-FDG metabolic imaging

Annals of nuclear medicine, 2017-07, Vol.31 (6), p.486-494

2017

Volltextzugriff (PDF)

68Ga-DOTA-DiPSMA PET/CT Imaging: Biodistribution, Dosimetry, and Preliminary Application in Prostate Cancer

Frontiers in bioengineering and biotechnology, 2022-01, Vol.9, p.811972-811972

2022

Volltextzugriff (PDF)

Comparison of 99mTc-3PRGD2 integrin receptor imaging with 99mTc-MDP bone scan in diagnosis of bone metastasis in patients with lung cancer: a multicenter study

PloS one, 2014, Vol.9 (10), p.e111221-e111221

2014

Volltextzugriff (PDF)

Inflammatory Pseudotumor of Intestine Mimicking Lymphoma on 18F-FDG PET/CT

Clinical nuclear medicine, 2020-05, Vol.45 (5), p.383

2020

Volltextzugriff (PDF)

68Ga-FAPI and 18F-PET/CT Images in Intestinal Tuberculosis

Clinical nuclear medicine, 2022-03, Vol.47 (3), p.239

2022

Volltextzugriff (PDF)

Head-to-Head Comparison of 68 Ga-NODAGA-JR11 and 68 Ga-DOTATATE PET/CT in Patients with Metastatic, Well-Differentiated Neuroendocrine Tumors: Interim Analysis of a Prospective Bicenter Study

Journal of Nuclear Medicine, 2023-09, Vol.64 (9), p.1406-1411

2023

Volltextzugriff (PDF)

Application of 99mTc-3PRGD2 imaging for predicting pathological complete response to neoadjuvant chemotherapy in breast cancer and axillary lymph nodes

The Journal of nuclear medicine (1978), 2018-05, Vol.59, p.1368

2018

Volltextzugriff (PDF)

Evaluating the value of ^sup 18^F-FDG PET/CT in Diagnosing Cervical lymph Node Metastasis of Oral and Maxillofacial Tumor

The Journal of nuclear medicine (1978), 2018-05, Vol.59, p.639

2018

Volltextzugriff (PDF)

sup 99m^Tc-3PRGD^sub 2^ for Integrin Receptor Imaging of Esophageal Cancer, Compared Study with ^sup 18^F-FDG PET/CT

The Journal of nuclear medicine (1978), 2018-05, Vol.59, p.1409

2018

Volltextzugriff (PDF)

Comparison of ^sup 99m^Tc-3PRGD^sub 2^ Imaging and ^sup 18^F-FDG PET/CT in Breast Cancer and Expression of Integrin α^sub v^β^sub 3^ in Breast Cancer Vascular Endothelial Cells

The Journal of nuclear medicine (1978), 2018-05, Vol.59, p.488

2018

Volltextzugriff (PDF)

[ 99m Tc]3PRGD 2 for integrin receptor imaging of esophageal cancer: a comparative study with [ 18 F]FDG PET/CT

Annals of nuclear medicine, 2019-02, Vol.33 (2), p.135

2019

Volltextzugriff (PDF)

68 Ga-Labeled Fibroblast Activation Protein Inhibitor PET/CT for the Early and Late Prediction of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer Patients: A Prospective Study

Journal of Nuclear Medicine, 2023-12, Vol.64 (12), p.1899-1905

2023

Volltextzugriff (PDF)

Correction to: A head-to-head comparison of [68Ga]Ga-DOTATATE and [68Ga]Ga-FAPI PET/CT in patients with nasopharyngeal carcinoma: a single-center, prospective study

European journal of nuclear medicine and molecular imaging, 2024-06

2024

Volltextzugriff (PDF)

Widespread Skin Infiltration of Leukemia Cutis on 18F-FDG PET/CT

Clinical nuclear medicine, 2020-11, Vol.45 (11), p.e489

2020

Volltextzugriff (PDF)

68Ga-FAPI Versus 18F-FDG PET/CT in Evaluating Newly Diagnosed Breast Cancer Patients: A Head-to-Head Comparative Study

Clinical nuclear medicine, 2023-03, Vol.48 (3), p.e104

2023

Volltextzugriff (PDF)

Primary Pancreatic Lymphoma Masquerading as Carcinoma on 18 F-FDG PET/CT

Clinical nuclear medicine, 2023-09, Vol.48 (9), p.820

2023

Volltextzugriff (PDF)

99mTc-3PRGD2 for integrin receptor imaging of lung cancer: a multicenter study

The Journal of nuclear medicine (1978), 2012-05, Vol.53 (5), p.716-722

2012

Volltextzugriff (PDF)

68 Ga-DOTA-FAPI-04 PET/CT imaging in radioiodine-refractory differentiated thyroid cancer (RR-DTC) patients

Annals of nuclear medicine, 2022-05

2022

Volltextzugriff (PDF)

Imaging and monitoring HER2 expression in breast cancer during trastuzumab therapy with a peptide probe 99mTc-HYNIC-H10F

European journal of nuclear medicine and molecular imaging, 2020-10, Vol.47 (11), p.2613-2623

2020

Volltextzugriff (PDF)

Apatinib versus placebo in patients with locally advanced or metastatic, radioactive iodine-refractory, differentiated thyroid cancer: Post hoc analyses from the REALITY randomized clinical trial

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.6095-6095

2022

Volltextzugriff (PDF)

Study of novel molecular probe 99mTc-3PRGD2 in the diagnosis of rheumatoid arthritis

Nuclear medicine communications, 2015-12, Vol.36 (12), p.1208-1214

2015

Volltextzugriff (PDF)

Atlas of PET/CT in Oncology - Volume 1: Brain, Head and Neck Cancers

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(37)

Publikationsform

Sprache

Englisch
(45)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(10)
Computed Tomography
(9)
Nuclear Medicine
(9)
Metastases
(8)
Patients
(8)
Single Photon Emission Computed Tomography
(8)
Lymph Nodes
(7)
Medical Imaging
(7)
Positron Emission Tomography
(7)
Tomography
(7)
Tumors
(7)
Cancer
(6)
Female
(6)
Fluorine Isotopes
(6)
Fluorodeoxyglucose F18
(6)
Imaging
(6)
Lesions
(6)
Medicine
(6)
Medicine & Public Health
(6)
Positron Emission Tomography Computed Tomography
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Expert Consensus on clinical application of FDG PET/CT in infection and inflammation

Characterization of the benign lesions with increased 68Ga-FAPI-04 uptake in PET/CT

[99mTc]3PRGD2 for integrin receptor imaging of esophageal cancer: a comparative study with [18F]FDG PET/CT

Evaluation of 99mTc-3PRGD2 integrin receptor imaging in hepatocellular carcinoma tumour-bearing mice: comparison with 18F-FDG metabolic imaging

68Ga-DOTA-DiPSMA PET/CT Imaging: Biodistribution, Dosimetry, and Preliminary Application in Prostate Cancer

Comparison of 99mTc-3PRGD2 integrin receptor imaging with 99mTc-MDP bone scan in diagnosis of bone metastasis in patients with lung cancer: a multicenter study

Inflammatory Pseudotumor of Intestine Mimicking Lymphoma on 18F-FDG PET/CT

68Ga-FAPI and 18F-PET/CT Images in Intestinal Tuberculosis

Head-to-Head Comparison of 68 Ga-NODAGA-JR11 and 68 Ga-DOTATATE PET/CT in Patients with Metastatic, Well-Differentiated Neuroendocrine Tumors: Interim Analysis of a Prospective Bicenter Study

Application of 99mTc-3PRGD2 imaging for predicting pathological complete response to neoadjuvant chemotherapy in breast cancer and axillary lymph nodes

Evaluating the value of ^sup 18^F-FDG PET/CT in Diagnosing Cervical lymph Node Metastasis of Oral and Maxillofacial Tumor

sup 99m^Tc-3PRGD^sub 2^ for Integrin Receptor Imaging of Esophageal Cancer, Compared Study with ^sup 18^F-FDG PET/CT

Comparison of ^sup 99m^Tc-3PRGD^sub 2^ Imaging and ^sup 18^F-FDG PET/CT in Breast Cancer and Expression of Integrin α^sub v^β^sub 3^ in Breast Cancer Vascular Endothelial Cells

[ 99m Tc]3PRGD 2 for integrin receptor imaging of esophageal cancer: a comparative study with [ 18 F]FDG PET/CT

68 Ga-Labeled Fibroblast Activation Protein Inhibitor PET/CT for the Early and Late Prediction of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer Patients: A Prospective Study

Correction to: A head-to-head comparison of [68Ga]Ga-DOTATATE and [68Ga]Ga-FAPI PET/CT in patients with nasopharyngeal carcinoma: a single-center, prospective study

Widespread Skin Infiltration of Leukemia Cutis on 18F-FDG PET/CT

68Ga-FAPI Versus 18F-FDG PET/CT in Evaluating Newly Diagnosed Breast Cancer Patients: A Head-to-Head Comparative Study

Primary Pancreatic Lymphoma Masquerading as Carcinoma on 18 F-FDG PET/CT

99mTc-3PRGD2 for integrin receptor imaging of lung cancer: a multicenter study

68 Ga-DOTA-FAPI-04 PET/CT imaging in radioiodine-refractory differentiated thyroid cancer (RR-DTC) patients

Imaging and monitoring HER2 expression in breast cancer during trastuzumab therapy with a peptide probe 99mTc-HYNIC-H10F

Apatinib versus placebo in patients with locally advanced or metastatic, radioactive iodine-refractory, differentiated thyroid cancer: Post hoc analyses from the REALITY randomized clinical trial

Study of novel molecular probe 99mTc-3PRGD2 in the diagnosis of rheumatoid arthritis

Atlas of PET/CT in Oncology - Volume 1: Brain, Head and Neck Cancers

Aktive Filter

Suchergebnisse filtern